ANL 22.80 Increased By ▲ 1.95 (9.35%)
ASC 14.65 Increased By ▲ 1.11 (8.2%)
ASL 23.97 Increased By ▲ 0.97 (4.22%)
BOP 8.40 Increased By ▲ 0.20 (2.44%)
BYCO 8.20 Increased By ▲ 0.39 (4.99%)
FCCL 18.02 Increased By ▲ 0.22 (1.24%)
FFBL 23.75 Increased By ▲ 1.00 (4.4%)
FFL 16.15 Increased By ▲ 0.65 (4.19%)
FNEL 8.14 Increased By ▲ 0.79 (10.75%)
GGGL 19.45 Increased By ▲ 1.62 (9.09%)
GGL 41.56 Increased By ▲ 1.55 (3.87%)
HUMNL 6.44 Increased By ▲ 0.42 (6.98%)
JSCL 19.65 Increased By ▲ 1.35 (7.38%)
KAPCO 37.15 Increased By ▲ 0.80 (2.2%)
KEL 3.48 Increased By ▲ 0.08 (2.35%)
MDTL 2.70 Increased By ▲ 0.05 (1.89%)
MLCF 35.50 Increased By ▲ 0.40 (1.14%)
NETSOL 138.55 Increased By ▲ 9.15 (7.07%)
PACE 5.32 Increased By ▲ 0.57 (12%)
PAEL 28.60 Increased By ▲ 1.60 (5.93%)
PIBTL 8.99 Increased By ▲ 0.14 (1.58%)
POWER 7.50 Increased By ▲ 0.05 (0.67%)
PRL 18.52 Increased By ▲ 1.37 (7.99%)
PTC 10.10 Increased By ▲ 0.09 (0.9%)
SILK 1.52 Increased By ▲ 0.02 (1.33%)
SNGP 46.20 Increased By ▲ 1.20 (2.67%)
TELE 19.89 Increased By ▲ 1.00 (5.29%)
TRG 171.95 Increased By ▲ 9.25 (5.69%)
UNITY 33.00 Increased By ▲ 0.05 (0.15%)
WTL 3.07 Increased By ▲ 0.13 (4.42%)
BR100 4,716 Decreased By ▼ -17.07 (-0.36%)
BR30 22,403 Decreased By ▼ -399.57 (-1.75%)
KSE100 45,075 Decreased By ▼ -221.72 (-0.49%)
KSE30 17,690 Decreased By ▼ -120.43 (-0.68%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
27,482
5024hr
Pakistan Cases
1,234,828
2,23324hr
4.23% positivity
Sindh
453,858
Punjab
426,639
Balochistan
32,828
Islamabad
104,764
KPK
172,498
World

Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use

  • Malaysia began its vaccination drive on Feb. 24 using a shot developed by US drugmaker Pfizer and German partner BioNTech, as it tries to rein in a spike in infections and help revive an economy that recorded its worst slump in more than two decades last year.
  • Sinovac signed a deal with Malaysia's Pharmaniaga, which will carry out a fill-and-finish process for the vaccine's distribution in Malaysia, before later manufacturing it locally.
02 Mar 2021

KUALA LUMPUR: Malaysia on Tuesday granted conditional approval for the use of vaccines made by UK firm AstraZeneca and China's Sinovac, just days after launching its nationwide COVID-19 inoculation programme.

Malaysia began its vaccination drive on Feb. 24 using a shot developed by US drugmaker Pfizer and German partner BioNTech, as it tries to rein in a spike in infections and help revive an economy that recorded its worst slump in more than two decades last year.

The conditional approval means Malaysia will use the vaccines developed by Astrazeneca and Sinovac, but both firms - along with Pfizer - will be required to provide additional data on rolling submissions to ensure the vaccines' effectiveness and safety, health director-general Noor Hisham Abdullah said in a statement.

Health authorities are also evaluating the COVID-19 vaccine produced by Russia's Gamaleya Research Institute, and the local bottling facility for Sinovac's vaccine, Noor Hisham said.

Sinovac signed a deal with Malaysia's Pharmaniaga, which will carry out a fill-and-finish process for the vaccine's distribution in Malaysia, before later manufacturing it locally.

Malaysia aims to vaccinate at least 80% of its population of about 32 million by February next year.

Last month, the government said it had secured 66.7 million vaccine doses, enough to more than cover its population.

Comments

Comments are closed.